Lung Cancer
In November 2017, the FDA approved Alecensa for the treatment of all patients with metastatic non–small-cell lung cancer (NSCLC) and ALK mutation. Read More ›
Dr. Bruce Gershenhorn explores 3 questions patients should ask after learning they have lung cancer. Knowledge is power. Read More ›
By Dana Taylor
Significant developments in the treatment of lung cancer were reported at the 2017 annual meeting of the European Society for Medical Oncology (ESMO) in Madrid, Spain. Read More ›
Low-dose CT screening is the only screening method recommended by the US Preventive Services Task Force for lung cancer, yet only 3.9% of eligible people are actually screened. Read More ›
Check out some of the most exciting immunotherapies that are giving hope to people fighting this disease, which is responsible for 1 in every 4 cancer-related deaths in the United States. Read More ›
Read Melissa Crouse’s resilient story of survival, as she deals with the surprising diagnosis of lung cancer as a nonsmoker. Read More ›
Prevention is an integral part of life. Since lung cancer causes more deaths than any other type of cancer, taking steps to prevent this deadly disease should be a “no-brainer.” Read More ›
By Tracy Wright
This is Taylor Duck's story of being diagnosed with lung cancer as a never-smoker. Read More ›
By Laura Morgan
Lung cancer is the leading cause of cancer-related deaths in the United States. According to the American Cancer Society, approximately 224,390 people will be diagnosed with lung cancer in 2016, and more than 158,000 patients will die from this disease. Smoking is the major risk factor for lung cancer–80% of lung cancer deaths are related to smoking. Read More ›
By Laura Morgan
It’s hard to believe that Kirk Smith, the 54-year-old owner of an advertising company, a triathlete, and a runner for the past 15 years or so, has lung cancer. Read More ›